Single-cell transcriptomic analysis reveals intra-tumoral heter-ogeneity and immunotherapy strategies in high-grade serous ovarian cancer
Fuente:
Zenodo
Guardado en:
| Autor principal: | wu, wenjuan |
|---|---|
| Formato: | Recurso digital |
| Publicado: |
Zenodo
2026
|
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
B cells critical for outcome in high grade serous ovarian carcinoma
por: Annegé Vledder, et al.
Publicado: (2024)
por: Annegé Vledder, et al.
Publicado: (2024)
Revisiting intraperitoneal chemotherapy for advanced high‐grade serous ovarian cancer
por: Joshua S Cheruvathur, et al.
Publicado: (2025)
por: Joshua S Cheruvathur, et al.
Publicado: (2025)
Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy
por: Luka Tandaric, et al.
Publicado: (2026)
por: Luka Tandaric, et al.
Publicado: (2026)
Plasma membrane SK2 channel activity regulates migration and chemosensitivity of high‐grade serous ovarian cancer cells
por: Olivier Romito, et al.
Publicado: (2024)
por: Olivier Romito, et al.
Publicado: (2024)
Identification of potential cell surface targets in patient‐derived cultures toward photoimmunotherapy of high‐grade serous ovarian cancer
por: Sudip Timilsina, et al.
Publicado: (2025)
por: Sudip Timilsina, et al.
Publicado: (2025)
Development and validation of a computational tool to predict treatment outcomes in cells from high‐grade serous ovarian cancer patients
por: Marilisa Cortesi, et al.
Publicado: (2025)
por: Marilisa Cortesi, et al.
Publicado: (2025)
Circulating serum miRNAs predict response to platinum chemotherapy in high‐grade serous ovarian cancer
por: Kazuhiro Suzuki, et al.
Publicado: (2024)
por: Kazuhiro Suzuki, et al.
Publicado: (2024)
Spatially resolved proteomics surveys the chemo‐refractory proteins related to high‐grade serous ovarian cancer
por: Linyuan Fan, et al.
Publicado: (2025)
por: Linyuan Fan, et al.
Publicado: (2025)
Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer
por: Sophia Bielesch, et al.
Publicado: (2026)
por: Sophia Bielesch, et al.
Publicado: (2026)
High expression of SLC7A1 in high‐grade serous ovarian cancer promotes tumor progression and is involved in MAPK/ERK pathway and EMT
por: Shijing You, et al.
Publicado: (2024)
por: Shijing You, et al.
Publicado: (2024)
Trps1 predicts poor prognosis in advanced high grade serous ovarian carcinoma
por: Xiaojiang Wang, et al.
Publicado: (2024)
por: Xiaojiang Wang, et al.
Publicado: (2024)
Plasma‐activated media selectively induces apoptotic death via an orchestrated oxidative stress pathway in high‐grade serous ovarian cancer cells
por: Lorena T. Davies, et al.
Publicado: (2024)
por: Lorena T. Davies, et al.
Publicado: (2024)
CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7 ‐ H3
por: Aya Saleh, et al.
Publicado: (2026)
por: Aya Saleh, et al.
Publicado: (2026)
Single‐cell transcriptome analysis reveals tumoral microenvironment heterogenicity and hypervascularization in human carotid body tumor
por: Gaopo Cai, et al.
Publicado: (2024)
por: Gaopo Cai, et al.
Publicado: (2024)
Tailored chemotherapy: Innovative deep‐learning model customizing chemotherapy for high‐grade serous ovarian carcinoma
por: Se Ik Kim, et al.
Publicado: (2024)
por: Se Ik Kim, et al.
Publicado: (2024)
Rates of genetic consultation in high‐grade serous ovarian cancer patients in the era of PARP inhibitor therapy: A population‐based study
por: Shannon E. Brent, et al.
Publicado: (2024)
por: Shannon E. Brent, et al.
Publicado: (2024)
Gene expression profiles associated with carboplatin chemoresistance in high-grade serous ovarian cancer: insights from 2D and 3D models
por: Konondoska Grič, Vesna, et al.
Publicado: (2026)
por: Konondoska Grič, Vesna, et al.
Publicado: (2026)
Identifying therapeutic targets in low‐grade serous ovarian carcinomas with no specific molecular profile
por: Kathleen I Pishas, et al.
Publicado: (2026)
por: Kathleen I Pishas, et al.
Publicado: (2026)
Single‐cell transcriptome analysis reveals heterogeneity of neutrophils in non‐small cell lung cancer
por: Yunzhen Wang, et al.
Publicado: (2024)
por: Yunzhen Wang, et al.
Publicado: (2024)
Detecting TP53 mutations in paired liquid and tissue biopsies from patients with high‐grade serous ovarian carcinoma
por: Amanda Olsson Widjaja, et al.
Publicado: (2025)
por: Amanda Olsson Widjaja, et al.
Publicado: (2025)
Economic impact of olaparib on maintenance treatment of patients with BRCA-mutation positive, platinum-sensitive relapsing high-grade serous epithelial ovarian cancer in Spain
por: Laura Delgado-Ortega
Publicado: (2018)
por: Laura Delgado-Ortega
Publicado: (2018)
Molecular and immunohistochemical characterization of ERBB2 activating mutations in low‐grade serous ovarian carcinoma
por: Alexander J Neil, et al.
Publicado: (2025)
por: Alexander J Neil, et al.
Publicado: (2025)
Single‐cell transcriptomic analysis reveals that the APP–CD74 axis promotes immunosuppression and progression of testicular tumors
por: Guo Chen, et al.
Publicado: (2024)
por: Guo Chen, et al.
Publicado: (2024)
Hypoxia‐mediated high expression of TRIM15 promotes malignant progression of high‐grade serous ovarian cancer through activation of AKT signaling pathway by K63 ubiquitination
por: Wei Wei, et al.
Publicado: (2025)
por: Wei Wei, et al.
Publicado: (2025)
A case of BRAF mutation‐positive recurrent ovarian high‐grade serous carcinoma with remarkable response to combined dabrafenib and trametinib therapy
por: Tatsuhito Furui, et al.
Publicado: (2025)
por: Tatsuhito Furui, et al.
Publicado: (2025)
Single‐cell transcriptomic analysis reveals a metastasis‐associated PCSK1 + neuroendocrine subpopulation in pancreatic neuroendocrine tumors
por: Xiaolei Yin, et al.
Publicado: (2025)
por: Xiaolei Yin, et al.
Publicado: (2025)
Comparative prognosis analysis of ovarian squamous cell carcinoma versus serous carcinoma: Insights from the SEER database
por: Xianglin Nie, et al.
Publicado: (2024)
por: Xianglin Nie, et al.
Publicado: (2024)
Single‐cell transcriptomics reveals IRF7 regulation of the tumor microenvironment in isocitrate dehydrogenase wild‐type glioma
por: Jinwei Li, et al.
Publicado: (2024)
por: Jinwei Li, et al.
Publicado: (2024)
Insights into the heterogeneity of the tumor microenvironment in lung adenocarcinoma and squamous carcinoma through single‐cell transcriptomic analysis: Implications for distinct immunotherapy outcomes
por: Xinyun Fang, et al.
Publicado: (2024)
por: Xinyun Fang, et al.
Publicado: (2024)
Single‐cell transcriptome sequencing reveals SPP1‐CD44‐mediated macrophage–tumor cell interactions drive chemoresistance in TNBC
por: Fuzhong Liu, et al.
Publicado: (2024)
por: Fuzhong Liu, et al.
Publicado: (2024)
Single‐cell transcriptomics reveals antigen‐presenting capacity and therapeutic resistance potential of immunomodulatory endothelial cells in colorectal cancer
por: Jingyi Wen
Publicado: (2024)
por: Jingyi Wen
Publicado: (2024)
CRISPR/Cas9‐edited tumor‐associated immune cells in cancer immunotherapy
por: Yuhui Ma, et al.
Publicado: (2025)
por: Yuhui Ma, et al.
Publicado: (2025)
Single‐cell transcriptomic analysis of B cells reveals new insights into atypical memory B cells in COVID‐19
por: Melissa García‐Vega, et al.
Publicado: (2024)
por: Melissa García‐Vega, et al.
Publicado: (2024)
Single‐cell transcriptomic analysis reveals APOE genotype‐dependent sex differences in Alzheimer's disease
por: Gefei Yu, et al.
Publicado: (2026)
por: Gefei Yu, et al.
Publicado: (2026)
Single‐cell transcriptome analysis reveals keratinocyte subpopulations contributing to psoriasis in corneum and granular layer
por: Qianya Zhao, et al.
Publicado: (2024)
por: Qianya Zhao, et al.
Publicado: (2024)
Deciphering head and neck cancer microenvironment: Single‐cell and spatial transcriptomics reveals human papillomavirus‐associated differences
por: Hansong Lee, et al.
Publicado: (2024)
por: Hansong Lee, et al.
Publicado: (2024)
Single‐cell transcriptomic landscape reveals distinct tumourigenesis and immune microenvironments in secondary radiation‐exposed rectal cancer
por: Xu Guan, et al.
Publicado: (2024)
por: Xu Guan, et al.
Publicado: (2024)
Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer
por: Laura Glossner, et al.
Publicado: (2025)
por: Laura Glossner, et al.
Publicado: (2025)
The potential value of cancer‐testis antigens in ovarian cancer: Prognostic markers and targets for immunotherapy
por: Lina Lin, et al.
Publicado: (2024)
por: Lina Lin, et al.
Publicado: (2024)
Targeting polymorphonuclear myeloid‐derived suppressor cells in the immunosuppressive tumor microenvironment for cancer immunotherapy
por: Shiqi Li, et al.
Publicado: (2024)
por: Shiqi Li, et al.
Publicado: (2024)
Ejemplares similares
-
B cells critical for outcome in high grade serous ovarian carcinoma
por: Annegé Vledder, et al.
Publicado: (2024) -
Revisiting intraperitoneal chemotherapy for advanced high‐grade serous ovarian cancer
por: Joshua S Cheruvathur, et al.
Publicado: (2025) -
Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy
por: Luka Tandaric, et al.
Publicado: (2026) -
Plasma membrane SK2 channel activity regulates migration and chemosensitivity of high‐grade serous ovarian cancer cells
por: Olivier Romito, et al.
Publicado: (2024) -
Identification of potential cell surface targets in patient‐derived cultures toward photoimmunotherapy of high‐grade serous ovarian cancer
por: Sudip Timilsina, et al.
Publicado: (2025)